A biomedical company is set to begin experiments using stem cells to revive brain dead patients in a manner that troubles theologians, who question whether this attempt to preempt the Messianic resurrection of the dead should be permitted. One prominent rabbi takes it even further, pointing out the clear and obvious flaw that destines the project to failure. Bioquark, a biomedical startup based in Philadelphia, recently announced that they will begin experiments later this year on patients who have been declared clinically brain dead. The trial will involve a multi-pronged approach, involving injecting stem cells and peptides into the spinal cords, electrical nerve stimulation, and laser therapy. The researchers hope this will grow new neurons and spur them to connect to each other, bringing the brain back to life.